Literature DB >> 3210004

A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.

J O Rinne1, E Säkö, L Paljärvi, P K Mölsä, U K Rinne.   

Abstract

Brain choline acetyltransferase (ChAT) activity was determined in 43 patients with Alzheimer's disease (AD), 14 with multi-infarct dementia (MID), and 15 with combined dementia (CD) and in 53 age-matched controls. The activity of ChAT declined in the hippocampus, temporal and frontal cortex in patients with AD and CD compared to the controls. In the AD group the reduced activity of ChAT in all brain areas was associated with a greater number of cortical neurofibrillary tangles. The degree of dementia had a negative correlation with the activity of ChAT in the frontal cortex in both AD and CD patients. The activity of ChAT in the temporal cortex of CD patients was negatively associated with the cortical tangle counts. In contrast, the activity of ChAT and MID patients was not essentially different from that of the controls. Neither did the various clinical and neuropathological variables show any significant correlation with ChAT activity in MID patients. Thus, in this study the reduction in the activity of ChAT seems to be associated with Alzheimer-type pathology but not with dementia due to vascular changes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3210004     DOI: 10.1007/bf01243383

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  18 in total

1.  MEASUREMENT OF MENTAL IMPAIRMENT IN GERIATRIC PRACTICE.

Authors:  B ISAACS; F A WALKEY
Journal:  Gerontol Clin (Basel)       Date:  1964

2.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

Authors:  D C Mash; D D Flynn; L T Potter
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

5.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

6.  Dopamine receptors in the Parkinsonian brain.

Authors:  U K Rinne; P Lönnberg; V Koskinen
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

Authors:  C Q Mountjoy; M N Rossor; L L Iversen; M Roth
Journal:  Brain       Date:  1984-06       Impact factor: 13.501

8.  Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

Authors:  M Ruberg; A Ploska; F Javoy-Agid; Y Agid
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

9.  Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.

Authors:  S Shimohama; T Taniguchi; M Fujiwara; M Kameyama
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

10.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.